Thiazolidinediones regulate adipose lineage dynamics

Wei Tang, Daniel Zeve, Jin Seo, A. Young Jo, Jonathan M. Graff

Research output: Contribution to journalArticle

51 Scopus citations

Abstract

White adipose tissue regulates metabolism; the importance of this control is highlighted by the ongoing pandemic of obesity and associated complications such as diabetes, atherosclerosis, and cancer. White adipose tissue maintenance is a dynamic process, yet very little is known about how pharmacologic stimuli affect such plasticity. Combining in vivo lineage marking and BrdU labeling strategies, we found that rosiglitazone, a member of the thiazolidinedione class of glucose-lowering medicines, markedly increases the evolution of adipose progenitors into adipocytes. Notably, chronic rosiglitazone administration disrupts the adipogenic and self-renewal capacities of the stem cell compartment and alters its molecular characteristics. These data unravel unknown aspects of adipose dynamics and provide a basis to manipulate the adipose lineage for therapeutic ends.

Original languageEnglish (US)
Pages (from-to)116-122
Number of pages7
JournalCell Metabolism
Volume14
Issue number1
DOIs
StatePublished - Jul 6 2011

ASJC Scopus subject areas

  • Physiology
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Thiazolidinediones regulate adipose lineage dynamics'. Together they form a unique fingerprint.

  • Cite this

    Tang, W., Zeve, D., Seo, J., Jo, A. Y., & Graff, J. M. (2011). Thiazolidinediones regulate adipose lineage dynamics. Cell Metabolism, 14(1), 116-122. https://doi.org/10.1016/j.cmet.2011.05.012